Experimental Hematology
Volume 35, Issue 4 , Pages 541-550 , April 2007

Growth factors G-CSF and GM-CSF differentially preserve chemotaxis of neutrophils aging in vitro

  • Baruch Wolach

      Affiliations

    • Sanquin Research at CLB and Landsteiner Laboratory , Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands
    • Department of Pediatrics, Meir Medical Center, Kfar Saba, Israel
    • Corresponding Author InformationOffprint requests to: Baruch Wolach, M.D., Department of Pediatrics, Meir Medical Center, Kfar Saba, Israel
    • These authors contributed equally to this work.
    • ,
  • Luc J.W. van der Laan

      Affiliations

    • Sanquin Research at CLB and Landsteiner Laboratory , Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands
    • The present address of Luc J.W. van der Laan is Erasmus University Medical Centre, Department of Gastroenterology and Hepatology, Liver Transplant Research Unit, Rotterdam, The Netherlands. The present address of Nikolai A. Maianski is Dept. of Microbiology and Immunology, Medical Academy, Nizhniy, Novgorod, Russia.
    • These authors contributed equally to this work.
    • ,
  • Nikolai A. Maianski

      Affiliations

    • Sanquin Research at CLB and Landsteiner Laboratory , Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands
    • The present address of Luc J.W. van der Laan is Erasmus University Medical Centre, Department of Gastroenterology and Hepatology, Liver Transplant Research Unit, Rotterdam, The Netherlands. The present address of Nikolai A. Maianski is Dept. of Microbiology and Immunology, Medical Academy, Nizhniy, Novgorod, Russia.
    • ,
  • Anton T.J. Tool

      Affiliations

    • Sanquin Research at CLB and Landsteiner Laboratory , Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands
    • ,
  • Robin van Bruggen

      Affiliations

    • Sanquin Research at CLB and Landsteiner Laboratory , Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands
    • ,
  • Dirk Roos

      Affiliations

    • Sanquin Research at CLB and Landsteiner Laboratory , Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands
    • ,
  • Taco W. Kuijpers

      Affiliations

    • Sanquin Research at CLB and Landsteiner Laboratory , Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands
    • Emma Children's Hospital, Academic Medical Centre, Amsterdam, The Netherlands

Received 2 May 2006 ,Revised 5 December 2006 ,Accepted 8 December 2006.

References 

  1. Akgul C, Moulding DA, Edwards SW. Molecular control of neutrophil apoptosis. FEBS Lett. 2001;487:318–322
  2. Homburg CH, Roos D. Apoptosis of neutrophils. Curr Opin Hematol. 1996;3:94–99
  3. Savill J. Apoptosis in resolution of inflammation. J Leukoc Biol. 1997;61:375–380
  4. Adams JM, Cory S. The Bcl-2 protein family: arbiters of cell survival. Science. 1998;281:1322–1326
  5. Thornberry NA, Lazebnik Y. Caspases: enemies within. Science. 1998;281:1312–1316
  6. Marzo I, Brenner C, Zamzami N, et al. The permeability transition pore complex: a target for apoptosis regulation by caspases and bcl-2-related proteins. J Exp Med. 1998;187:1261–1271
  7. Hengartner MO. The biochemistry of apoptosis. Nature. 2000;407:770–776
  8. Maianski NA, Mul FP, van Buul JD, Roos D, Kuijpers TW. Granulocyte colony-stimulating factor inhibits the mitochondria-dependent activation of caspase-3 in neutrophils. Blood. 2002;99:672–679
  9. Dransfield I, Stocks SC, Haslett C. Regulation of cell adhesion molecule expression and function associated with neutrophil apoptosis. Blood. 1995;85:3264–3273
  10. Whyte MK, Meagher LC, MacDermot J, Haslett C. Impairment of function in aging neutrophils is associated with apoptosis. J Immunol. 1993;150:5124–5134
  11. Brach MA, de Vos S, Gruss HJ, Herrmann F. Prolongation of survival of human polymorphonuclear neutrophils by granulocyte-macrophage colony-stimulating factor is caused by inhibition of programmed cell death. Blood. 1992;80:2920–2924
  12. Van den Berg JM, Weyer S, Weening JJ, Roos D, Kuijpers TW. Divergent effects of tumor necrosis factor alpha on apoptosis of human neutrophils. J Leukoc Biol. 2001;69:467–473
  13. Sullivan GW, Carper HT, Mandell GL. The effect of three human recombinant hematopoietic growth factors (granulocyte-macrophage colony-stimulating factor, granulocyte colony-stimulating factor, and interleukin-3) on phagocyte oxidative activity. Blood. 1993;81:1863–1870
  14. Spiekermann K, Roesler J, Emmendoerffer A, Elsner J, Welte K. Functional features of neutrophils induced by G-CSF and GM-CSF treatment: differential effects and clinical implications. Leukemia. 1997;11:466–478
  15. Wolach B, Gavrieli R, Pomeranz A. Effect of granulocyte and granulocyte macrophage colony stimulating factor (G-CSF and GM-CSF) on neonatal neutrophil functions. Pediatr Res. 2000;48:369–373
  16. Roos D, De Boer M. Purification and cryopreservation of phagocytes from human blood. Methods Enzymol. 1986;132:225–243
  17. Van Engeland M, Nieland LJ, Ramaekers FC, Schutte B, Reutelingsperger CP. Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry. 1998;31:1–9
  18. Chuntharapai A, Kim KJ. Regulation of the expression of IL-8 receptor A/B by IL-8: possible functions of each receptor. J Immunol. 1995;155:2587–2594
  19. Nagase H, Miyamasu M, Yamaguchi M, et al. Cytokine-mediated regulation of CXCR4 expression in human neutrophils. J Leukoc Biol. 2002;71:711–717
  20. Kuijpers TW, Maianski NA, Tool ATJ, et al. Apoptotic neutrophils in the circulation of patients with glycogen storage disease type 1b (GSD1b). Blood. 2003;101:5021–5024
  21. Kuijpers TW, Van den Berg JM, Tool ATJ, Roos D. The impact of platelet-activating factor (PAF)-like mediators on the functional activity of neutrophils: anti-inflammatory effects of human PAF-acetylhydrolase. Clin Exp Immunol. 2001;123:412–420
  22. Hii CS, Stacey K, Moghaddami N, Murray AW, Ferrante A. Role of the extracellular signal-regulated protein kinase cascade in human neutrophil killing of Staphylococcus aureus and Candida albicans and in migration. Infect Immun. 1999;67:1297–1302
  23. Valenzuela-Fernandez A, Planchenault T, Baleux F, et al. Leukocyte elastase negatively regulates Stromal cell-derived factor-1 (SDF-1)/CXCR4 binding and functions by amino-terminal processing of SDF-1 and CXCR4. J Biol Chem. 2002;277:15677–15689
  24. Van Pelt LJ, Huisman MV, Weening RS, Von dem Borne AE, Roos D, Van Oers RA. A single dose of granulocyte-macrophage colony-stimulating factor induces systemic interleukin-8 release and neutrophil activation in healthy volunteers. Blood. 1996;87:5305–5313
  25. Quehenberger O, Prossnitz ER, Cavanagh SL, Cochrane CG, Ye RD. Multiple domains of the N-formyl peptide receptor are required for high-affinity ligand binding. Construction and analysis of chimeric N-formyl peptide receptors. J Biol Chem. 1993;268:18167–18175
  26. Bleul CC, Fuhlbrigge RC, Casasnovas JM, Aiuti A, Springer TA. A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J Exp Med. 1996;184:1101–1109
  27. Martin C, Burdon PCE, Bridger G, Guttierrez-Ramos JC, Williams TJ, Rankin SM. Chemokines acting via CXCR2 and CXCR4 control the release of neutrophils from the bone marrow and their return following senescence. Immunity. 2003;19:583–593
  28. Suzuki K, Hasegawa T, Sakamoto C, et al. Cleavage of mitogen-activated protein kinases in human neutrophils undergoing apoptosis: role in decreased responsiveness to inflammatory cytokines. J Immunol. 2001;166:1185–1192
  29. Suzuki K, Hino M, Hato F, Tatsumi N, Kitagawa S. Cytokine-specific activation of distinct mitogen-activated protein kinase subtype cascades in human neutrophils stimulated by granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, and tumor necrosis factor-alpha. Blood. 1999;93:341–349
  30. Loetscher M, Geiser T, O'Reilly T, Zwahlen R, Baggiolini M, Moser B. Cloning of a human seven-transmembrane domain receptor, LESTR, that is highly expressed in leukocytes. J Biol Chem. 1994;269:232–237
  31. Neote K, DiGregorio D, Mak JY, Horuk R, Schall TJ. Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor. Cell. 1993;72:415–425
  32. Bruhl H, Wagner K, Kellner H, Schattenkirchner M, Schlondorff D, Mack M. Surface expression of CC- and CXC-chemokine receptors on leucocyte subsets in inflammatory joint diseases. Clin Exp Immunol. 2001;126:551–559
  33. Lum JJ, Bren G, McClure R, Badley AD. Elimination of senescent neutrophils by TNF-related apoptosis-inducing ligand. J Immunol. 2005;175:1232–1238
  34. Richardson RM, Pridgen BC, Haribabu B, Ali H, Snyderman R. Differential cross-regulation of the human chemokine receptors CXCR1 and CXCR2. Evidence for time-dependent signal generation. J Biol Chem. 1998;273:23830–23836
  35. Murphy PM, Ozcelik T, Kenney RT, Tiffany HL, McDermott D, Francke U. A structural homologue of the N-formyl peptide receptor. Characterization and chromosome mapping of a peptide chemoattractant receptor family. J Biol Chem. 1992;267:7637–7643
  36. Ahuja SK, Murphy PM. The CXC chemokines growth-related oncogene (GRO)α GROß, GROγ, neutrophil-activating peptide-2 and epithelial cell-derived neutrophil-activating peptide-78 (ENA-78) are potent agonists for the type B, but not the type A, human interleukin-8 receptor. J Biol Chem. 1996;271:20545–20550
  37. Ethuin F, Delarche C, Benslama S, Gougerot-Pocidalo MA, Jacob L, Chollet-Martin S. Interleukin-12 increases interleukin 8 production and release by human polymorphonuclear neutrophils. J Leukoc Biol. 2001;70:439–446
  38. Van Pelt LJ. Effects of GM-CSF on neutrophils in vivo and in vitro. 1996. PhD Thesis, University of Amsterdam, The Netherlands.
  39. Cummings CJ, Martin TR, Frevert CW, et al. Expression and function of the chemokine receptors CXCR1 and CXCR2 in sepsis. J Immunol. 1999;162:2341–2346
  40. Chishti AD, Dark JH, Kesteven P, et al. Expression of chemokine receptors CXCR1 and CXCR2 during cardiopulmonary bypass. J Thorac Cardiovasc Surg. 2001;122:1162–1166
  41. Chishti AD, Shenton BK, Kirby JA, Baudouin SV. Neutrophil chemotaxis and receptor expression in clinical septic shock. Intensive Care Med. 2004;30:605–611
  42. Tarlowe MH, Duffy A, Kannan KB, et al. Prospective study of neutrophil chemokine responses in trauma patients at risk for pneumonia. Am J Respir Crit Care Med. 2005;171:753–759
  43. Greenstein S, Barnard J, Zhou K, Fong M, Hendey B. Fas activation reduces neutrophil adhesion to endothelial cells. J Leukoc Biol. 2000;68:715–722

PII: S0301-472X(06)00764-8

doi: 10.1016/j.exphem.2006.12.008

Experimental Hematology
Volume 35, Issue 4 , Pages 541-550 , April 2007

Article Tools

* Image Usage & Resolution